Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK2A1 | P68400 | 2/20 | 0.55 |
| ▸ | MCHR1 | Q99705 | 2/20 | 0.49 |
| ▸ | HTR1B | P28222 | 9/20 | 0.49 |
| ▸ | HTR1D | P28221 | 3/20 | 0.44 |
| ▸ | CNR1 | P21554 | 1/20 | 0.44 |
| ▸ | CNR2 | P34972 | 1/20 | 0.44 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.41 |
| ▸ | HRH1 | P35367 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15345351 | 0.88 | CSNK2A1 (0.55) | CSNK2A1MCHR1HTR1BHTR1DTLR8 | |
| SCHEMBL15345486 | 0.88 | HTR1B (0.44) | CSNK2A1HTR1BTLR8CYP2A6 | |
| SCHEMBL15345390 | 0.81 | DHODH (0.46) | MCHR1HTR1B | |
| SCHEMBL7835596 | 0.80 | CYP2A6 (0.50) | MCHR1HTR1BHTR1DCNR1CNR2 | |
| SCHEMBL15473247 | 0.80 | HTR1B (0.49) | MCHR1HTR1BHTR1DCNR1CNR2 | |
| SCHEMBL15772531 | 0.80 | MTNR1A (0.52) | MCHR1HTR1BHTR1DCNR1CNR2 | |
| Ammonia Solution, Strong SCHEMBL27919268 | 0.78 | CYP2A6 (0.49) | MCHR1HTR1BHTR1DCNR1CNR2 | |
| SCHEMBL7835592 | 0.78 | HTR1B (0.48) | MCHR1HTR1BHTR1DCNR1CNR2 | |
| SCHEMBL15473235 | 0.77 | MTNR1A (0.51) | MCHR1HTR1BHTR1DCNR1CNR2 | |
| SCHEMBL2116954 | 0.77 | HTR1B (0.70) | HTR1BHTR1DCNR1CNR2SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2657214-B1 | PROCESS FOR PRODUCTION OF AROMATIC ALCOHOL OR HETEROCYCLIC AROMATIC ALCOHOL | MITSUBISHI GAS CHEMICAL CO (JP) | 2017-02-15 | — | — | EP | disclosed |
| US-8993774-B2 | Process for production of aromatic alcohol or heterocyclic aromatic alcohol | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2015-03-31 | — | — | US | disclosed |
| US-20130303775-A1 | PROCESS FOR PRODUCTION OF AROMATIC ALCOHOL OR HETEROCYCLIC AROMATIC ALCOHOL | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2013-11-14 | — | — | US | disclosed |
| EP-2657214-A1 | PROCESS FOR PRODUCTION OF AROMATIC ALCOHOL OR HETEROCYCLIC AROMATIC ALCOHOL | Mitsubishi Gas Chemical Company, Inc. (JP) | 2013-10-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130303775-A1 | PROCESS FOR PRODUCTION OF AROMATIC ALCOHOL OR HETEROCYCLIC AROMATIC ALCOHOL | ADH1C, ADH1A, ADH5 | CSNK2A1 2918/4885MCHR1 50/4885HTR1B 163/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.